3M Drug Delivery to Manufacture Transdermal Patch in Europe
3M Drug Delivery will manufacture transdermal patch for ProStrakan.
The specialty pharmaceutical company ProStrakan Group has received approval from EMA to market Sancuso (granisetron transdermal system) in the European Union, with 3M Drug Delivery Systems acting as the manufacturer. ProStrakan began marketing the product in October 2013 in the United Kingdom, Germany, and the Netherlands. Additional European countries are expected to be added in 2014.
Initially introduced in the United States in 2008, Sancuso is used to treat chemotherapy-induced nausea and vomiting. The transdermal patch is applied to the upper arm and can be worn for seven days, providing continuous transdermal delivery and eliminating the need to take pills daily to control nausea and vomiting.
ProStrakan previously relied on a different manufacturer for the US supply of Sancuso. FDA approval is currently pending for the 3M Drug Delivery Systems manufactured product.
Source: 3M Drug Delivery Systems
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
